The extent of type 2 cytokine gene expression in patients with pulmonary tuberculosis (TB) was studied by use of quantitative nested reverse-transcription polymerase chain reaction on freshly isolated peripheral blood mononuclear cells. Interleukin (IL)-4 and IL-13 mRNA expression was significantly greater in patients-median mRNA copy numbers were 1.7 and 1.1 log 10 higher, respectively-than in matched tuberculin-positive control subjects. Significant correlations with radiologic extent of disease and serum IgE levels supported the biologic significance of these results. Interferon-g mRNA copy numbers exceeded those of type 2 cytokines but were only marginally lower in patients than in control subjects. Gene expression of an IL-4 splice variant (IL-4d2) was bimodally distributed in both patient and control groups. Patients with greater IL-4d2 expression also expressed more IL-4 mRNA and had more extensive disease. Type 2 cytokines are associated with immunopathologic changes in TB patients but could be a cause or consequence of disease.
to be unchanged, with no evidence of increased resistance to the infection [4] .
The confusion may be partly attributed to the diverse methodologies used and inherent difficulties in performing IL-4 assays, because very low levels of IL-4 are produced by unstimulated cells. However, stimulating the cells in culture media with various antigens and cytokines is unlikely to yield a physiologic response that reflects the in vivo cytokine milieu. The IL-4 genedeficient mouse model may not give definitive answers either, because IL-13 also has type 2 cytokine activity [5] . In addition, none of the previous TB studies have taken into account the presence and possible activity of an IL-4 splice variant (IL4d2), which is detectable even in normal subjects [6] and has potential immunomodulatory functions [7] .
We established a sensitive assay that allows type 2 cytokine gene expression to be quantified in fresh, unstimulated peripheral blood mononuclear cells (PBMC) from any subject, healthy or with disease [8] . We looked for differences in mRNA expression of IL-4, IL-4d2, or IL-13 between patients with TB and healthy tuberculin-positive control subjects, compared this to IFN-g expression, and sought to relate cytokine expression levels to clinical parameters.
Materials and Methods
Patients and control subjects. Whole blood was obtained from 18 patients (age range, 18-64 years) whose first episode of pulmonary TB was confirmed by clinical findings, radiography, and sputum culture. Their ethnic origins were representative of the resident population in central London. Patients with a history of Figure 1 . Interleukin (IL)-4 and IL-13 mRNA copy numbers in tuberculosis (TB) patients were significantly greater than those in control subjects; and , respectively, by the Mann-Whit-P = .004 P = .0009 ney nonparametric test. Conversely, interferon (IFN)-g mRNA levels were higher in control subjects ( ). Median results are shown, P = .08 with 25th and 75th percentiles marked as error bars.
atopy, steroid use, or other concomitant infectious or autoimmune diseases were excluded.
A blood sample was taken from the patients either before or within the first month of starting treatment. Chest radiographs (CXRs) at presentation and follow-up were available for all patients. The extent of disease in each patient was assessed by 3 parameters-sputum smear for acid-fast bacilli (AFB), extent of involvement shown on CXR, and presence or absence of cavitation.
Control subjects were healthy, tuberculin-reactive, recent close contacts of patients with active pulmonary TB. Eighteen such subjects were individually matched to the patient cohort by age, sex, ethnicity, and geographic region of origin. They had no known history of bacille Calmette-Guérin (BCG) immunization or clinical evidence of a BCG scar. These control subjects were asymptomatic and had no history of chronic illnesses or atopy. Their CXR findings were normal. Their total white cell counts, differential counts, C-reactive protein levels, and erythrocyte sedimentation rates were all within normal limits. This control group was chosen because, within the limits of interpretation of the tuberculin test, such subjects are most likely to represent those recently exposed to but not with disease.
PBMC isolation and reverse transcription-polymerase chain reaction (RT-PCR)
. The assay has been described in detail elsewhere [8] . In brief, PBMC were isolated from fresh whole blood by density-gradient centrifugation, and RNA was extracted from the PBMC by the phenol-chloroform method. A cRNA standard for each cytokine studied was constructed. A 10-fold dilution series of each of these synthetic cRNAs was used as an external standard for subsequent RT-PCRs. RT and 2-tube nested PCR protocols have been published elsewhere [8] . Additional PCR primers used were as follows (5 r3 ): The first-round IFN-g primers were GGC-TGTTACTGCCAGGACCCATATGT and GATGCTCTTCGA-CCTCGAAACAGCAT; the second-round primers were GCAGG-TCATTCAGATGTAGCGGAT and AGCCATCACTTGGATG-AGTTCATG. For IL-13, the first-round primers were CCACGG-TCATTGCTCTCACTT and TTACAAACTGGGCCACCTC-GA; the second-round primers were CAACATCACCCAGAACC-AGAAG and CAGAATCCGCTCAGCATCCTC.
The PCR amplicons were detected directly from fluorescentstained gels with an image analyzer, as described in detail elsewhere [8] , and quantified by interpolation from the linear standard curves derived from amplicons of the cRNA standard series for each cytokine. The number of copies of mRNA for each cytokine was normalized against b-actin gene expression, to standardize results with respect to the initial RNA yield.
ELISA. Levels of serum IgE were determined by use of ELISA kits from ALPCO (Windham, NH), in accordance with the manufacturer's instructions.
Statistical methods. Cytokine mRNA expression in different samples was compared by use of the nonparametric Mann-Whitney U test. Results in the figures are expressed as medians, and error bars show 25th and 75th percentiles. The Spearman rank-sum correlation was used to test the significance of correlations.
Results

Clinical parameters.
Of the 18 TB patients, 14 were smearpositive for AFB, and 10 had evidence of cavitation on their CXRs. Nine patients had either minimal or moderate disease, and 9 had extensive disease, on the basis of whether р3 (minimal/moderate) or 13 (extensive) radiographic zones were affected by tuberculous disease.
IL-4d2. IL-4d2 mRNA was detected in all subjects, which is consistent with previous reports [6] . Exon 1 continues as exon 3 in this transcript, without frameshift (sequencing data not shown). The expression of mRNA for IL-4d2 was bimodal in both patient and control groups. The 2 populations within each group were designated IL-4d2 hi and IL-4d2 lo . Within the IL4d2 hi population, TB patients expressed significantly more copies of mRNA for IL-4d2 than did control subjects ( ). P = .04 The same is true for subjects within the IL-4d2 lo group (P = ). IL-4d2 hi patients ( ) had significantly higher median .002 n = 8 levels of IL-4 mRNA expression ( ) than did IL-4d2 lo P = .04 patients (
). Expression of IL-13 mRNA was also higher n = 10 and that of IFN-g lower in the former group, but these differences were not statistically significant. The IL-4d2 hi patients, as a group, were more likely to have extensive disease and visible cavitation on their CXRs at presentation than were IL4d2 lo patients, although the difference was not statistically significant.
Type 2 cytokine gene expression in TB. IL-4 and IL-13 mRNA expression was markedly greater in the PBMC of the patients with TB when compared with that in control subjects (figure 1). Median IL-4 and IL-13 mRNA log copy numbers were 1.7 and 1.1 logs higher, respectively, than control values ( and , respectively). There was a significant P = .004 P = .0009 positive correlation between IL-4 and IL-13 expression in both patient and control groups ( ). The IFN-g : IL-4 P = .00001 mRNA copy number ratio was markedly higher in control subjects (median, 573.21, compared with 8.877 in patients; P = ). .002
To assess the biologic significance of the increased mRNA expression in patients, serum IgE levels were assayed as a surrogate marker of type 2 cytokine biologic activity [9] . Serum IgE levels were significantly correlated with IL-4 mRNA copy numbers in patients ( ) and in control subjects ( P = .032 P = ), which is consistent with the known role of IL-4 in IgE .001 isotype switching. We also found that serum IgE levels in the TB patients were significantly higher than those in control subjects, by the Mann-Whitney nonparametric test ( ). P = .017 Correlation with clinical parameters. Expression of IL-4 mRNA correlated with clinical measures of disease severity (figure 2). Radiologically advanced disease and cavitation on CXR, as well as sputum smear positivity for AFB on clinical presentation, were all associated with greater IL-4 mRNA expression. The association of disease extent shown on radiography with IL-4 mRNA expression was statistically significant ( ). Interestingly, there was also a lower IFN-g : IL-4 P = .04 mRNA copy number ratio in patients with greater extent of disease shown on their CXRs ( ). P ! .05 Discussion IL-4 detection. Previous studies using conventional assays have reported IL-4 to be almost undetectable in PBMC from TB patients and normal subjects [10] ; the levels of detectable IL-4 are so low that the data cannot be adequately interpreted. The nested RT-PCR assay that we used has a 5-log 10 working range [8] , and we believe its sensitivity allows us to study type 2 cytokine expression more accurately, since IL-4 mRNA expression can be quantified even in unstimulated cells from normal subjects.
